IGFBP7 and acute kidney injury: Since sCr and UOP are inaccurate markers of renal function, novel urinary biomarkers such as uNGAL and TIMP-2*IGFBP7 may be helpful for the early recognition and treatment of neonates at risk for mild to severe AKI, also because they are non-invasive determinations.